儿科癌症队列中的生殖基因突变与混合祖先的墨西哥人
Oscar Alonso-Luna1, Gabriela E Mercado-Celis2, Jorge Melendez-Zajgla3
1Programa de Maestria y Doctorado en Ciencias Medicas, Odontologicas y de la Salud, Ciudad Universitaria, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico.
Molecular genetics & genomic medicine
|December 14, 2023
概括
这项研究确定了15%的墨西哥儿科癌症患者癌症倾向基因的生殖系突变. 这些发现突出了遗传风险因素,并提高了对这种代表性不足的人群中儿童癌症的理解.
科学领域:
- 基因组学就是基因组学.
- 儿科瘤学 儿科瘤学
- 人口遗传学 人口遗传学
背景情况:
- 儿童癌症是5至14岁儿童死亡的主要原因.
- 与成人癌症不同,儿童癌症具有显著的遗传成分.
- 在遗传学研究中,拉丁美洲人口的代表性不足.
研究的目的:
- 为了分析墨西哥儿科癌症患者的生殖基因突变.
- 调查混合祖先人口中的遗传风险因素.
主要方法:
- 来自40名墨西哥儿童癌症患者和亲属的DNA全外体测序.
- 使用GATK最佳实践进行变种识别.
- 人口遗传学分析.
主要成果:
- 六名患者 (15%) 携带已知癌症倾向基因 (例如CDKN2A,CHEK2,DICER1) 的生殖基因突变.
- 使用in silico预测识别了新的有害变体.
- 人口遗传学分析揭示了与墨西哥人口统计模型一致的五个组成部分.
结论:
- 在墨西哥儿科患者中确定了儿童癌症的潜在遗传风险因素.
- 对这一群体儿童癌症的遗传基础有了更深入的了解.
- 强调需要在代表性不足的群体进行进一步的基因组研究.
相关概念视频
Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Mutations
82.8K
Overview
82.8K
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K


